Barclays PLC Maravai Lifesciences Holdings, Inc. Transaction History
Barclays PLC
- $436 Billion
- Q2 2025
A detailed history of Barclays PLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Barclays PLC holds 214,885 shares of MRVI stock, worth $674,738. This represents 0.0% of its overall portfolio holdings.
Number of Shares
214,885
Previous 214,885
-0.0%
Holding current value
$674,738
Previous $517,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding MRVI
# of Institutions
175Shares Held
130MCall Options Held
426KPut Options Held
37.5K-
Gtcr LLC20.2MShares$63.3 Million5.18% of portfolio
-
12 West Capital Management LP New York, NY12.5MShares$39.3 Million3.78% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$30.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.38MShares$29.5 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$26.2 Million1.23% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $413M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...